JP2008530090A5 - - Google Patents

Download PDF

Info

Publication number
JP2008530090A5
JP2008530090A5 JP2007555124A JP2007555124A JP2008530090A5 JP 2008530090 A5 JP2008530090 A5 JP 2008530090A5 JP 2007555124 A JP2007555124 A JP 2007555124A JP 2007555124 A JP2007555124 A JP 2007555124A JP 2008530090 A5 JP2008530090 A5 JP 2008530090A5
Authority
JP
Japan
Prior art keywords
cci
polymorph
solid
polymorph form
bme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007555124A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008530090A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/003098 external-priority patent/WO2006086172A1/en
Publication of JP2008530090A publication Critical patent/JP2008530090A/ja
Publication of JP2008530090A5 publication Critical patent/JP2008530090A5/ja
Withdrawn legal-status Critical Current

Links

JP2007555124A 2005-02-09 2006-01-25 Ｃｃｉ−７７９多形及びその使用 Withdrawn JP2008530090A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65137405P 2005-02-09 2005-02-09
PCT/US2006/003098 WO2006086172A1 (en) 2005-02-09 2006-01-25 Cci-779 polymorph and use thereof

Publications (2)

Publication Number Publication Date
JP2008530090A JP2008530090A (ja) 2008-08-07
JP2008530090A5 true JP2008530090A5 (https=) 2009-03-05

Family

ID=36570939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007555124A Withdrawn JP2008530090A (ja) 2005-02-09 2006-01-25 Ｃｃｉ−７７９多形及びその使用

Country Status (19)

Country Link
US (1) US7442707B2 (https=)
EP (1) EP1856130A1 (https=)
JP (1) JP2008530090A (https=)
KR (1) KR20070107030A (https=)
CN (1) CN101115759A (https=)
AR (1) AR052479A1 (https=)
AU (1) AU2006213061A1 (https=)
BR (1) BRPI0607932A2 (https=)
CA (1) CA2595766A1 (https=)
CR (1) CR9257A (https=)
GT (1) GT200600044A (https=)
IL (1) IL184560A0 (https=)
MX (1) MX2007009590A (https=)
NO (1) NO20073725L (https=)
PE (1) PE20060996A1 (https=)
RU (1) RU2007129264A (https=)
TW (1) TW200638932A (https=)
WO (1) WO2006086172A1 (https=)
ZA (1) ZA200706628B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8551512B2 (en) * 2004-03-22 2013-10-08 Advanced Cardiovascular Systems, Inc. Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS
WO2007067566A2 (en) * 2005-12-07 2007-06-14 Wyeth Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
CN101321770A (zh) * 2005-12-07 2008-12-10 惠氏公司 由雷帕霉素42-酯硼酸酯制备雷帕霉素42-酯的可放大方法
AR058282A1 (es) * 2005-12-07 2008-01-30 Wyeth Corp Forma cristalina purificada de cci-779, un proceso para la preparacion del mismo, un metodo para monitorear la cristalizacion del cci-779, un kit y una composicion farmaceutica que lo comprenden y su uso en la fabricacion de un medicamento para el tratamiento del cancer.
TW200824713A (en) * 2006-10-18 2008-06-16 Wyeth Corp Processes for the synthesis of individual isomers of mono-PEG CCI-779
CN102282457A (zh) * 2009-01-21 2011-12-14 拜康有限公司 确定西罗莫司稳定性的方法和制备其稳定形式的工艺
US10682415B2 (en) 2013-07-22 2020-06-16 Wisconsin Alumni Research Foundation Thermogel formulation for combination drug delivery
CN109020995A (zh) * 2017-06-12 2018-12-18 鲁南制药集团股份有限公司 一种替西罗莫司的晶型物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US6277983B1 (en) 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
TWI256395B (en) 1999-09-29 2006-06-11 Wyeth Corp Regioselective synthesis of rapamycin derivatives
DK1419154T3 (da) 2001-08-22 2006-01-09 Wyeth Corp Rapamycin-29-enoler
EP1419153A1 (en) 2001-08-22 2004-05-19 Wyeth Rapamycin dialdehydes
EP1646635A1 (en) 2003-07-16 2006-04-19 Wyeth Cci-779 isomer c
JP4227649B2 (ja) 2003-08-07 2009-02-18 ワイス Ｃｃｉ−７７９の位置選択的合成
UA84881C2 (ru) 2003-09-03 2008-12-10 Уайт Аморфный 42-эфир рапамицина и 3-гидрокси-2-(гидроксиметил)-2-метилпропионовой кислоты и фармацевтическая композиция, содержащая его
JP4224115B2 (ja) 2004-04-14 2009-02-12 ワイス ラパマイシン４２−エステル誘導体の位置特異的合成

Similar Documents

Publication Publication Date Title
RU2007104518A (ru) Полиморф рапамицина ii и его применение
KR101454937B1 (ko) 면역조절제로서 피리딘-3-일 유도체
JP2005503386A5 (https=)
JP2018520178A5 (https=)
JPH0631300B2 (ja) 結晶性アジスロマイシン２水和物及びその製法
JP2008530090A5 (https=)
JP2010539237A5 (https=)
WO2013175506A2 (en) Process for sorafenib tosylate polymorph iii
RU2007129264A (ru) Полиморф cci-779 и его применение
CN107698574B (zh) 一种高纯度阿瑞匹坦的精制制备工艺
CN105693746A (zh) 噁唑烷酮类化合物的制备方法及其中间体
WO2012037764A1 (zh) （e）-2-[2-（6-氯嘧啶-4-基氧）苯基]-3-甲氧基丙烯酸甲酯的制备方法
CA2806820A1 (en) N-methylformamide solvate of dasatinib
JP5642766B2 (ja) アデフォビルジピボキシルの新規結晶形及びその製造方法
WO2011061611A1 (en) Process for the preparation of form b of lenalidomide
WO2011147279A1 (zh) 5-[[2(r)-[1(r)-[3,5-双(三氟甲基)苯基]乙氧基]-3(s)-4-(氟苯基)-4-吗啉基]甲基]-1,2-二氢-3h-1,2,4-三唑-3-酮的制备方法
JP2008524183A5 (https=)
TW202313599A (zh) 式i化合物的晶型及其製備和應用
CA2734896A1 (en) Therapeutic substituted pyrroles
CN106432253B (zh) 一种维帕他韦新晶型及其制备方法
WO2008130534A1 (en) Crystalline forms of topotecan hydrochloride and processes for making the same
US20080200724A1 (en) Process and Compound
WO2021127986A1 (zh) 一种制备尼古丁的方法
EP1934183A1 (en) Methods of preparing anhydrous aripiprazole form ii
CN112262121A (zh) 用于制备他喷他多的新方法